| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to rheumatology. Method of rheumatoid arthritis treatment includes therapy by non-steroid anti-inflammatory medications, glucocorticosteroids and cytostatics, and patient is additionally prescribed selenase 1 time per day in form of intravenous drop infusions in dose 2 ml (100 mcg), diluted in 200 ml of physiologicalsolution, during 10 days, with following transfer to per oral application of selenase in dose 2 ml (100 mcg of selenium) 1 time per day, course lasting to 6 months. ^ EFFECT: invention ensures increase of rheumatoid arthritis treatment efficiency and correction of autoimmune processes in case of said disease, makes it possible to reduce clinical symptoms of rheumatoid arthritis, reduce treatment terms, improve immunity properties and life quality of said category of patients. ^ 2 ex |
